Nigeria approves use of AstraZeneca COVAX vaccines before vaccination



[ad_1]

Nigerian authorities on Friday approved the use of the AstraZeneca Covid-19 vaccine as part of the COVAX facility after being assessed, a development that clears the coast for vaccination in the South African country. ‘Where is.

The National Agency for Food, Administration and Control of Medicines (NAFDAC), which carried out the final evaluation of the vaccine, certified it as suitable for use, said the National Agency for the Development of Care. Primary Health Care Center (NPHCDA), which coordinates vaccine delivery. in Nigeria, in a statement.

This development precedes the vaccination of frontline health workers and Nigerian President Muhammadu Buhari, as well as his deputy and strategic leaders, who are expected to take their first doses of the vaccine.

“After undergoing a final assessment by NAFDAC, we have confirmation that they have concluded their final checks with positive results. Nigeria can now use the 3.94 million doses of AstraZeneca vaccine, ”the statement said.

The country received 3.94 million doses of AstraZeneca / Oxford Covid-19 vaccines on Tuesday, the highly anticipated first batch of vaccines from the COVAX facility.

It is the first of these shipments that is expected to be made to Nigeria as part of efforts to control the spread of Covid-19.

Following the arrival of the vaccine on Tuesday, samples were handed over to NAFDAC for safety review.

Faisal Shuaib, the executive director of NPHCDA, told reporters at a press briefing in Abuja on Thursday that frontline health workers would be vaccinated at Abuja National Hospital on Friday, while Buhari and his deputy Yemi Osinbajo would receive their own vaccines on Saturday.

[ad_2]
Source link